Iodoantipyrine
Appearance
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.516 |
Chemical and physical data | |
Formula | C11H11IN2O |
Molar mass | 314.126 g·mol−1 |
3D model (JSmol) | |
| |
|
Iodoantipyrine is a drug developed in the 1950s. It has antiinflammatory effects, and also has antiviral action by inducing interferon production. It has been used in Russia for treatment of tick-borne encephalitis, but is more commonly used in recent times in its radiolabelled form for tracking blood flow.[1][2][3][4]
See also
[edit]- Aminophenazone
- Phenazone (Antipyrine)
- Propyphenazone
References
[edit]- ^ Glazer LC. "Methods for determination of optic nerve blood flow". The Yale Journal of Biology and Medicine. 61 (1): 51–60. PMID 3284212.
- ^ Iavorovskaia VE, Saratikov AS, Fedorov Iu, Solianik RG, Anosova GV, Lepekhin AV, et al. "[Iodoantipyrine--an agent for treating and preventing tick-borne encephalitis]". Eksperimental'naia i Klinicheskaia Farmakologiia. 61 (1): 51–53. PMID 9575413.
- ^ Krylova NV, Iakusheva SS, Borisevich VG, Leonova GN. "[Changes in the immune status parameters and their correction in various forms of tick-borne encephalitis]". Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]. 46 (7): 23–26. PMID 11697240.
- ^ Zochodne DW (2002). "Nerve and ganglion blood flow in diabetes: an appraisal". International Review of Neurobiology. 50: 161–202. doi:10.1016/S0074-7742(02)50077-5. ISBN 978-0-12-366850-9. PMID 12198810.